Company Performance Metrics
- Stan van Oppen: CFO
- Peter Van Paassen: Co-Founder and COO
Sensius fundamentally changes the risk-reward balance when treating cancer. Addition of Sensius’ thermotherapy to cancer treatment improves both outcome and quality of life, where mainstay treatments (radio- and chemotherapy) are inherently toxic. Sensius is a medical device company that has built a bespoke cancer therapy device using proprietary
thermal technology and software. The device is designed by clinicians who use their skills and experience to craft unique thermal collars to treat initially head and neck cancer. Seventy patients have been treated with the device. A study demonstrated 81.8% of the patients having a complete response at 12 weeks following radiotherapy. The Company is now moving to build a CE marked device: already 20 interested parties are intending to purchase the device as soon as it is CE/FDA-marked. A roadmap for other cancer treatments is available.
